Protease Activity in Vascular Disease.
作者信息
Slack Megan A, Gordon Scott M
机构信息
From the Saha Cardiovascular Research Center and Department of Physiology, University of Kentucky College of Medicine, Lexington.
出版信息
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):e210-e218. doi: 10.1161/ATVBAHA.119.312413. Epub 2019 Sep 25.
Abstract
摘要
相似文献
1
Protease Activity in Vascular Disease.血管疾病中的蛋白酶活性
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):e210-e218. doi: 10.1161/ATVBAHA.119.312413. Epub 2019 Sep 25.
2
A commentary on the paper titled "protease activity in the multi-layered intra-luminal thrombus of abdominal aortic aneurysms" for Atherosclerosis.一篇针对发表于《动脉粥样硬化》杂志上题为《腹主动脉瘤多层腔内血栓中的蛋白酶活性》论文的评论。
Atherosclerosis. 2011 Oct;218(2):283-4. doi: 10.1016/j.atherosclerosis.2011.05.042. Epub 2011 Jul 6.
3
4
High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.高密度脂蛋白是蛋白酶活性的调节剂：对炎症、补体激活和动脉粥样硬化血栓形成的影响。
Atherosclerosis. 2017 Apr;259:104-113. doi: 10.1016/j.atherosclerosis.2016.11.015. Epub 2016 Nov 16.
5
Oxidized lipids: the two faces of vascular inflammation.氧化脂质：血管炎症的两面
Curr Atheroscler Rep. 2006 May;8(3):223-31. doi: 10.1007/s11883-006-0077-x.
6
Associations between serum relaxin 2, aneurysm formation/size and severity of atherosclerosis: a preliminary prospective analysis.血清松弛素 2 与动脉瘤形成/大小及动脉粥样硬化严重程度的相关性：一项初步前瞻性分析。
Acta Pharmacol Sin. 2018 Jul;39(7):1243-1248. doi: 10.1038/aps.2018.8. Epub 2018 Mar 22.
7
Status of biomarkers for the identification of stable or vulnerable plaques in atherosclerosis.动脉粥样硬化中稳定或易损斑块的生物标志物的研究现状。
Clin Sci (Lond). 2021 Aug 27;135(16):1981-1997. doi: 10.1042/CS20210417.
8
Atherosclerosis: cell biology and lipoproteins--shear stress and inflammation in plaque formation: new evidence.动脉粥样硬化：细胞生物学与脂蛋白——斑块形成中的剪切应力与炎症：新证据
Curr Opin Lipidol. 2008 Dec;19(6):627-8. doi: 10.1097/MOL.0b013e328318db32.
9
Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology.血管稳态和疾病中的微囊泡。欧洲心脏病学会（ESC）动脉粥样硬化和血管生物学工作组立场文件。
Thromb Haemost. 2017 Jun 28;117(7):1296-1316. doi: 10.1160/TH16-12-0943. Epub 2017 Jun 1.
10
Platelets and platelet-derived microparticles in vascular inflammatory disease.血管炎性疾病中的血小板和血小板衍生微粒
Inflamm Allergy Drug Targets. 2010 Dec;9(5):346-54. doi: 10.2174/187152810793938008.
引用本文的文献
1
PERRC: Protease Engineering with Reactant Residence Time Control.PERRC：通过反应物停留时间控制进行蛋白酶工程
ACS Synth Biol. 2025 Jun 20;14(6):2241-2253. doi: 10.1021/acssynbio.5c00154. Epub 2025 May 19.
2
PERRC: Protease Engineering with Reactant Residence Time Control.PERRC：通过反应物停留时间控制进行蛋白酶工程
bioRxiv. 2025 Mar 4:2025.03.02.641063. doi: 10.1101/2025.03.02.641063.
3
Vascular Pathology in Alpha 1 Antitrypsin Deficient Chronic Obstructive Pulmonary Disease and Emphysema Patients: Case Reports.α1抗胰蛋白酶缺乏性慢性阻塞性肺疾病和肺气肿患者的血管病理学：病例报告
Appl Clin Genet. 2025 Jan 28;18:1-7. doi: 10.2147/TACG.S491890. eCollection 2025.
4
Activatable Photosensitizers: From Fundamental Principles to Advanced Designs.可激活光敏剂：从基本原理到先进设计
Angew Chem Int Ed Engl. 2025 Apr 7;64(15):e202423348. doi: 10.1002/anie.202423348. Epub 2025 Feb 21.
5
Vascular Extracellular Matrix in Atherosclerosis.血管细胞外基质在动脉粥样硬化中的作用
Int J Mol Sci. 2024 Nov 8;25(22):12017. doi: 10.3390/ijms252212017.
6
Nonlinear dynamics of multi-omics profiles during human aging.人类衰老过程中多组学特征的非线性动力学。
Nat Aging. 2024 Nov;4(11):1619-1634. doi: 10.1038/s43587-024-00692-2. Epub 2024 Aug 14.
7
Enhancement of high-density lipoprotein-associated protease inhibitor activity prevents atherosclerosis progression.增强高密度脂蛋白相关蛋白酶抑制剂活性可预防动脉粥样硬化进展。
Atherosclerosis. 2024 Sep;396:118544. doi: 10.1016/j.atherosclerosis.2024.118544. Epub 2024 Jul 16.
8
A Protease from Moringa oleifera Lam. Exhibits In-vitro Blood Clot Solubilization and Fibrin Hydrolysis.辣木蛋白酶具有体外溶解血凝块和纤维蛋白水解的作用。
Protein J. 2024 Aug;43(4):923-934. doi: 10.1007/s10930-024-10222-z. Epub 2024 Jul 28.
9
Elevation of Serum Prostate-Specific Antigen Levels in Males With Pulmonary Embolism.男性肺栓塞患者血清前列腺特异性抗原水平升高。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241250002. doi: 10.1177/10760296241250002.
10
Peptidome Profiling of Urine and Assessment of Its Antimicrobial Activity against Mastitis-Causing Pathogens.尿液的肽组分析及其对引起乳腺炎病原体的抗菌活性评估
Antibiotics (Basel). 2024 Mar 26;13(4):299. doi: 10.3390/antibiotics13040299.
本文引用的文献
1
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation.靶向治疗动脉粥样硬化炎症中的中性粒细胞胞外诱捕网。
Thromb Haemost. 2019 Apr;119(4):542-552. doi: 10.1055/s-0039-1678664. Epub 2019 Feb 7.
2
Selective Inhibition of PAR4 (Protease-Activated Receptor 4)-Mediated Platelet Activation by a Synthetic Nonanticoagulant Heparin Analog.一种合成非抗凝肝素类似物对 PAR4（蛋白酶激活受体 4）介导的血小板活化的选择性抑制。
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):694-703. doi: 10.1161/ATVBAHA.118.311758.
3
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.凝血蛋白酶和 PARs（蛋白酶激活受体）在炎症性疾病小鼠模型中的作用。
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):13-24. doi: 10.1161/ATVBAHA.118.311655.
4
Highlight on Endothelial Activation and Beyond.聚焦于内皮细胞激活及其他方面。
Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):e198-e201. doi: 10.1161/ATVBAHA.118.312054.
5
Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.16 种高密度脂蛋白（HDL）亚型中的独特蛋白质组学特征。
Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2827-2842. doi: 10.1161/ATVBAHA.118.311607.
6
Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time-dependent manner during atherothrombosis.在动脉血栓形成过程中，巨噬细胞、肥大细胞、嗜酸性粒细胞和中性粒细胞衍生的细胞外陷阱是呈时间依赖性产生的。
J Pathol. 2019 Apr;247(4):505-512. doi: 10.1002/path.5212. Epub 2019 Jan 25.
7
Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.肿瘤坏死因子-α（TNF-α）-TNF-Rp55（肿瘤坏死因子受体 p55）轴在静脉血栓消退中的作用。
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2638-2650. doi: 10.1161/ATVBAHA.118.311194.
8
Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.输注载有重组 ADAMTS13（一种具有血小板反应素 1 型重复的解整合素和金属蛋白酶）的血小板可有效抑制与血栓性血小板减少性紫癜相关的动脉血栓形成。
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2731-2743. doi: 10.1161/ATVBAHA.118.311407.
9
USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.USP20（泛素特异性蛋白酶 20）抑制 TNF（肿瘤坏死因子）触发的平滑肌细胞炎症并减轻动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2295-2305. doi: 10.1161/ATVBAHA.118.311071.
10
High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.高密度脂蛋白蛋白质组与心血管危险因素和动脉粥样硬化负担相关，可通过冠状动脉 CT 血管造影评估。
Atherosclerosis. 2018 Nov;278:278-285. doi: 10.1016/j.atherosclerosis.2018.09.032. Epub 2018 Sep 25.
Zotero 插件